https://www.selleckchem.com/pr....oducts/iruplinalkib.
sults with clinical data improves the model's ability to assess glaucoma progression and better reflects the way clinicians manage data when managing glaucoma. A convolutional LSTM architecture can capture local and global trends in VFs over time. It is well suited to assessing glaucoma progression because of its ability to extract spatiotemporal features that other algorithms cannot. Supplementing VF results with clinical data improves the model's ability to assess glaucoma progression and better reflects the way clinicians manage